FLT3 and acute myeloid leukemia: The prevalence of FLT3-ITD mutation in childhood AML usually presents stepwise increase with age and thus its frequency in infant AML is significantly lower (2 and 5% of patients aged <1 year and 1 to <2 years, respectively) than in older children (8, 21).